Search results - 8 results

Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study.

Hepatitis A Hepatitis C Humans Infant, Newborn Pandemics prevalence Viremia Abstract: BACKGROUND: Since the release of the first global hepatitis elimination targets in 2016, and until the COVID-19 pandemic ...

Prevalence Estimation Of HCV Among People Who Inject Drugs In Belgium Through Respondent Driven Sampling, Capture-Recapture And Multiplier Method

Estimates about the number of people living with HCV in Belgium are rare and even less is known about the prevalence of HCV among PWID. Methods: Between February and April 2019, PWID were recruited in ...

Hepatitis C virus prevalence in Belgium

C population estimate Seroprevalence Abstract: Reliable hepatitis C prevalence estimates are crucial for a good follow-up of the indicators to eliminate hepatitis by 2030 as set by the World Health Organization. ...

Hepatitis C virus prevalence in Belgium

C population estimate Seroprevalence Abstract: Reliable hepatitis C prevalence estimates are crucial for a good follow-up of the indicators to eliminate hepatitis by 2030 as set by the World Health Organization. ...

Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.

Verburgh; Marjorie Meurisse; Steven Van Gucht; Veronik Hutse Source: BMC Public Health, Volume 19, Issue 1 (2019) Abstract: BACKGROUND: Prevalence data of chronic hepatitis C virus (HCV) infection are needed ...

Distribution of HCV genotypes in Belgium from 2008 to 2015.

RESULTS: For the study period, 11,033 unique records collected by the participating laboratories were used for further investigation. HCV genotype 1 was the most prevalent (53.6%) genotype in Belgium, with ...

Hepatitis E virus serology and PCR: does the methodology matter?

quality control (EQC) samples. In a period of 39 months (January 2011-April 2014), 70 patients were enrolled. Using different ELISA assays, the prevalence of antibodies varied from 5.7% to 14.3% for HEV IgM ...

Diagnostic hepatitis C testing of people in treatment for substance use disorders in Belgium between 2011 and 2014: a cross-sectional study.

Keywords: Belgium cross-sectional studies Hepacivirus Hepatitis C Humans Mass Screening Substance Abuse, Intravenous Abstract: BACKGROUND: Hepatitis C prevalence figures for people who use drugs in Belgium ...

QR code

QR code for this page URL